Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin treatment of acute optic neuritis: double-blind randomized placebo-controlled phase III trial
2005-004838-40Phase 3Completed
- Sponsor
- Rigshospitalet Glostrup
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in optic neuritis (ON) and multiple sclerosis (MS) comparing Simvastatin with Placebo (2 arms). Primary endpoints: Contrast sensitivity of the affected eye at 3 months and Development of disseminated multiple sclerosis at 6 months. Started Jan 2006; status: completed.
02
Drugs
simvastatin
03
Conditions
optic neuritis (ON)multiple sclerosis (MS)
Beyond the preview
Go deeper on 2005-004838-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004838-40.